Company Description
Hywin Holdings Ltd., through its subsidiaries, provides wealth management, asset management, health management, insurance brokerage, and other financial services in China.
It operates through two segments: Wealth and Health. The company distributes asset-backed products, such as real estate securitization products, as well as equity investments in real estate projects or private project companies; venture capital, private equity, and hedge funds; and supply chain financing and cash management products.
It also offers public market investment products, including money market funds, such as government bonds, central bank bills, term and certificates of deposits, and corporate commercial papers; bond funds comprising government, corporate, and convertible bonds, as well as other traded debt instruments; and equities and multi-strategy funds.
In addition, the company provides individual whole life insurance, individual term life insurance, universal life insurance, individual health insurance, and annuity insurance products, as well as critical illness insurance, including personal accident insurance products.
Further, it manages and distributes various private funds to professional investors; offers discretionary and advisory mandates to ultra-high-net-worth clients; rents and manages properties; and provides residential property investment services, including client referrals to overseas and charge property developers.
Additionally, the company provides healthcare solutions, such as medical examinations, chronic disease management, immune system enhancement, and anti-aging solutions, as well as mild aesthetic medicines; and information technology services, including transaction process management, data analysis, and system maintenance services to asset management service and financial product providers.
Hywin Holdings Ltd. was founded in 2006 and is headquartered in Shanghai, China. Hywin Holdings Ltd. operates as a subsidiary of Grand Lead Group Limited.
| Country | China |
| Founded | 2006 |
| IPO Date | Mar 26, 2021 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 2,905 |
Contact Details
Address: F3, Hywin Financial Centre, 8 Yincheng Mid. Road, Pudong New Dist. Shanghai, F4 200120 China | |
| Phone | 8602180133888 |
Stock Details
| Ticker Symbol | STEC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | CNY |
| IPO Price | $10.00 |
| CIK Code | 0001785680 |
| ISIN Number | US44951X1046 |
| SIC Code | 6282 |
Key Executives
| Name | Position |
|---|---|
| Dian Wang | Chief Executive Officer and Director |
| Hongwei Han | Founder and Chairman of the Board |
| Wai Lok | Chief Financial Officer |
| Hua Zhu | Chief Technology Officer |
| Zheng Liu | Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 17, 2024 | 6-K | Report of foreign issuer |
| Jul 17, 2024 | 424B3 | Prospectus |
| Jun 28, 2024 | 6-K | Report of foreign issuer |
| Jun 28, 2024 | 6-K | Report of foreign issuer |
| Jun 28, 2024 | 6-K | Report of foreign issuer |
| Jun 7, 2024 | 6-K | Report of foreign issuer |
| Jun 6, 2024 | 6-K | Report of foreign issuer |
| May 30, 2024 | 6-K | Report of foreign issuer |
| Mar 27, 2024 | 6-K | Report of foreign issuer |
| Dec 14, 2023 | 6-K | Report of foreign issuer |